Avenue Therapeutics, Inc. is a specialty pharmaceutical company focused on developing drug product candidates. Its primary pipeline includes IV tramadol, an intravenous formulation of the analgesic tramadol, and ATX-04. The company has no approved products for commercial sale. It previously held rights to AJ201 (licensed from AnnJi Pharmaceutical) and BAER101 (via Baergic Bio), both of which have been divested. Avenue is a majority-controlled subsidiary of Fortress Biotech, Inc.
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001437749-26-010359 | EDGAR | 85K words |
| 2025-03-31 | 2024-12-31 | 0001437749-25-010196 | EDGAR | — |
| 2024-03-18 | 2023-12-31 | 0001437749-24-008294 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001410578-23-000557 | EDGAR | — |
| 2022-03-25 | 2021-12-31 | 0001410578-22-000516 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001104659-21-044358 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001104659-20-040345 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001144204-19-013543 | EDGAR | — |
| 2018-03-01 | 2017-12-31 | 0001144204-18-012321 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001437749-26-026372 | EDGAR | — |
| 2025-11-13 | 2025-09-30 | 0001437749-25-034821 | EDGAR | 21K words |
| 2025-08-14 | 2025-06-30 | 0001437749-25-026935 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001437749-25-017180 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001437749-24-035309 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001437749-24-025880 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001437749-24-017062 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001437749-23-031621 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001437749-23-023335 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001437749-23-014236 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001410578-22-003151 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001410578-22-002605 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-23 | 0001104659-26-018582 | EDGAR | 1K words |
| 2025-12-31 | 0001104659-25-125420 | EDGAR | — |
| 2025-11-18 | 0001437749-25-035624 | EDGAR | — |
| 2025-11-12 | 0001437749-25-034243 | EDGAR | — |
| 2025-04-30 | 0001104659-25-042570 | EDGAR | — |
| 2025-03-17 | 0001104659-25-024505 | EDGAR | — |
| 2025-03-07 | 0001437749-25-006685 | EDGAR | — |
| 2024-11-29 | 0001104659-24-124081 | EDGAR | — |
| 2024-11-14 | 0001437749-24-035304 | EDGAR | — |
| 2024-09-27 | 0001437749-24-030185 | EDGAR | — |
189 total filings indexed. 158 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001644963 |
| Ticker | ATXI |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ATXI (~200 tokens, structured JSON with cryptographic provenance)